65 -- CONSOLIDATED VACCINE FOR CHILDREN CONTRACTS

Notice Date

November 27, 2000

Contracting Office

Department of Health and Human Services, Center for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, GA, 30341-4146

ZIP Code

30341-4146

Solicitation Number

2001-N-00029

Response Due

January 16, 2001

Point of Contact

Rex Ellington, Contract Specialist, Phone (770)488-2615, Fax (770)488-2670, Email REllington@CDC.GOV -- Danny Hager, Supervisory Contract Specialist, Phone (770)488-2609, Fax (770)488-2670, Email DHager@CDC.GOV

E-Mail Address

Rex Ellington (REllington@CDC.GOV)

Description

The Centers for Disease Control and Prevention (CDC) is soliciting proposals for the award of multiple indefinite delivery, indefinite quantity contracts for the purchase of childhood vaccines included under the Vaccine For Children (VFC) program, pursuant to, Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA). CDC anticipates the award of one consolidated contract to each vaccine manufacturer to include all vaccines required by the VFC program which the manufacturer produces. The applicable VFC vaccines are: Diphtheria and Tetanus Toxoid with Acellular Pertussis (DTaP), Diphtheria and Tetanus Toxoid with Acellular Pertussis Combined with Haemophilus Influnzae Type b (DTaP/Hib), Enhanced Inactivated Polio (E-IPV), Hepatitis A Pediatric, Hepatitis B Pediatric/Adolescent that does not contain Thimerosal as a Preservative, Hepatitis B Combined with Haemophilus Influenza Type b (Heb B/Hib), Haemophilus Influenza Type b (Hib), Measles, Mumps, Rubella, Combination Measles, Mumps & Rubella, Varicella and Pneumococcal Conjugate (7 Valent). Maximum estimated quantities, minimum order sizes, shelf life requirements and applicable price restrictions will be listed in the solicitation. Vaccines shall be shipped F.O.B. Destination to the 50 states and U.S. Territories. Contracts shall be for a twelve month period beginning o/a 04/01/01. Offerors must provide evidence of a current FDA establishment license and evidence of current FDA product licenses for all proposed products and must meet the definition of a manufacturer as stipulated by OBRA 93. Solicitation Number 2001-N-00029 will be issued o/a 12/14/00. Only written requests for the solicitation directly from the requestor will be acceptable, including facsimile requests to (770) 488-2670. No telephone requests.

Web Link

Visit this URL for the latest information about this (http://www2.eps.gov/cgi-bin/WebObjects/EPS.woa/wa/SPF?A=P&P=2001-N-00029&L=2965)

Record

Loren Data Corp. 20001129/65SOL003.HTM (D-332 SN5074N9)